Varian's planning software gets US FDA go-ahead:
This article was originally published in Clinica
Executive Summary
Varian Medical Systems has received US FDA 510(k) clearance to market its image-based, three-dimensional treatment planning software BrachyVision 6.0. The software is used to develop plans for low-dose rate brachytherapy as well as temporary implants of radiation sources for high-dose rate brachytherapy in patients with cancer of the cervix, lung, prostate, breast and head and neck, said the Palo Alto, California-based company.